News

Stille delivered growth both organically as well as through the acquisition of Swiss company S&T AG. Organic sales grew by 12% compared to the same quarter previous year. “The acquisition of S&T means that business unit Surgical Instruments has doubled in size. The integration of the company is progressing according to plan. Our main focus is to realize identified cross-selling synergies...

For more information, please contact: Hanna Ernestam Wilkman CEO +46 (0)72 402 10 88 | hanna.e.wilkman@stille.se STILLE AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical...

Revenues for the second quarter increased by 39 percent to 40.6 MSEK (29.3) and operating profit to 5.2 MSEK (-1.5) compared to previous year. The growth is applicable to both Surgical Instruments (44 percent) and C-arm Tables (35 percent). “I am pleased to see that demand for our products is returning in all markets where we are active, and it is particularly positive that the growth for both...

S&T AG was founded in 1966 and has its headquarters and manufacturing in Neuhausen, Switzerland. S&T is globally recognized as one of the world’s leading manufacturers of high-quality microsurgical instruments. The company’s products are marketed through around 50 distributors throughout the world, with the US, the UK and Germany as the most important markets. ”The acquisition...

Revenues for the first quarter decreased slightly to 35.8 MSEK (36.8) and the operating profit to 4.0 (4.7) compared to previous year. A minor reduction, however, with a strong quarter from Surgical Instruments in Sweden with revenues up 23%, CEO Hanna Ernestam Wilkman comments on what is the first interim report of Stille’s 180th year in business. The decrease in revenues is instead attributed...

Stille’s Annual Report for the business year of 2020 is today being published and can be found on the company website www.stille.se. The Annual Report 2020 can also be found in full as an attachment to this press release. Torshälla, March 31st 2021 For more information, please contact: Hanna Ernestam Wilkman CEO +46 (0)72 402 10 88 | hanna.e.wilkman@stille.se STILLE AB (publ) develops...

Turnover for the fourth quarter increased to 45.0 MSEK (40.8) and operating profit to 8.7 MSEK (6.3). For the full year 2020, turnover reached 142.6 MSEK (156.7) and operating profit 10.2 MSEK (18.2). It has been a tough year, but it is great that we end the year with a historically strong quarter where all business areas and product lines display growth compared to previous year, says the CEO and...

One of the most common risks during and after surgery are hemorrhages, which are sometimes caused by poor visualization in the surgical site. Light Jacket® solves this problem by offering an additional bright light source continuously directed at the surgical site without disrupting the focus of the surgeon. The Light Jacket® is a simple yet smart disposable product that fits directly onto...

Revenue in the third quarter decreased to 31.5 MSEK (40.7) and the operating profit to 2.6 MSEK (8.9) compared to the previous year. This after a tough start of the quarter affected by COVID-19, followed by a strong finish. The operating profit was positively impacted by economic relief packages relating to COVID-19 by 1.0 MSEK. After a tough start we are now seeing a gradual return of the demand for...

Revenue in the second quarter was negatively affected by COVID-19 and decreased by 20.4 percent compared to the same quarter previous year. Revenue amounted to 29.3 MSEK (36.8). The operating profit decreased to -1.5 MSEK (5.1) and was negatively impacted by items affecting comparability of 5.4 MSEK following depreciation of stock and a weakened US dollar. Simultaneously, the operating profit was positively...